These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6621857)

  • 1. Confirmatory and exploratory analysis applied to pharmaco-EEG and related study data: contradiction or useful enrichment?
    Ferner U; Matejcek M; Neff G
    Neuropsychobiology; 1983; 9(2-3):182-92. PubMed ID: 6621857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaco-EEG experiments in animals.
    Stumpf C
    Neuropsychobiology; 1984; 12(2-3):179-82. PubMed ID: 6396529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaco-electroencephalography: the value of quantified EEG in psychopharmacology.
    Matejcek M
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Mar; 12(2):126-36. PubMed ID: 461500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Analysis of Pharmaco-EEG Data in Humans.
    Jobert M; Wilson FJ
    Neuropsychobiology; 2015; 72(3-4):165-77. PubMed ID: 26900936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaco-EEG profiles of typical and atypical antidepressants.
    Saletu B
    Adv Biochem Psychopharmacol; 1982; 32():257-68. PubMed ID: 7090895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in pharmaco-electroencephalography.
    Fingelkurts AA; Fingelkurts AA; Kähkönen S
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):193-9. PubMed ID: 15694226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of magnetoencephalography in the study of psychopharmacology (pharmaco-MEG).
    Muthukumaraswamy SD
    J Psychopharmacol; 2014 Sep; 28(9):815-29. PubMed ID: 24920134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
    Herrmann WM; Schärer E; Wendt G; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
    Herrmann WM; Schärer E; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical problems in the analysis of comparative pharmaco-EEG trials.
    Abt K
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Mar; 12(2):228-36. PubMed ID: 461509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some methodological aspects on the statistical analysis of pharmaco-EEG data.
    Ferner U
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Mar; 12(2):220-7. PubMed ID: 461508
    [No Abstract]   [Full Text] [Related]  

  • 12. Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging).
    Saletu B; Anderer P; Kinsperger K; Grünberger J
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):385-408. PubMed ID: 2888937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological guidelines for reading drug-evaluation research.
    King PR
    Can J Psychiatry; 1984 Nov; 29(7):575-82. PubMed ID: 6509424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longisectional interaction structure analysis (LISA) in psychopharmacology and developmental psychopathology.
    Lienert GA; Bergman LR
    Neuropsychobiology; 1985; 14(1):27-34. PubMed ID: 2415869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological considerations for the evaluation of EEG mapping data: a practical example based on a placebo/diazepam crossover trial.
    Jähnig P; Jobert M
    Neuropsychobiology; 1995; 31(1):31-46. PubMed ID: 7708179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG results.
    Anderer P; Barbanoj MJ; Saletu B; Semlitsch HV
    Neuropsychobiology; 1993; 27(2):112-6. PubMed ID: 8515827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group.
    Ferber G; Abt K; Fichte K; Luthringer R
    Neuropsychobiology; 1999; 39(2):92-100. PubMed ID: 10072666
    [No Abstract]   [Full Text] [Related]  

  • 19. Statistiscal analysis of the distributions of integrated EEG in psychopharmacology.
    Etevenon P; Guillon G; Boissier JR
    Agressologie; 1969 Jun; 10():Suppl:641-5. PubMed ID: 5377596
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
    Herrmann WM; Schärer E; Wendt G; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):206-13. PubMed ID: 1812497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.